Jon S Saxe - Net Worth and Insider Trading
Jon S Saxe Net Worth
The estimated net worth of Jon S Saxe is at least $33,372 dollars as of 2024-11-10. Jon S Saxe is the Director of Durect Corp and owns about 17,781 shares of Durect Corp (DRRX) stock worth over $23,649. Jon S Saxe is the Director of Vistagen Therapeutics Inc and owns about 1,775 shares of Vistagen Therapeutics Inc (VTGN) stock worth over $5,574. Jon S Saxe is also the Director of PDL BioPharma Inc and owns about 1,680 shares of PDL BioPharma Inc (PDLI) stock worth over $4,150. Details can be seen in Jon S Saxe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jon S Saxe has not made any transactions after 2020-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jon S Saxe
Jon S Saxe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jon S Saxe owns 6 companies in total, including Vistagen Therapeutics Inc (VTGN) , Durect Corp (DRRX) , and SciClone Pharmaceuticals Inc (SCLN) among others .
Click here to see the complete history of Jon S Saxe’s form 4 insider trades.
Insider Ownership Summary of Jon S Saxe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VTGN | Vistagen Therapeutics Inc | 2020-08-21 | director |
| DRRX | Durect Corp | 2019-06-10 | director |
| SCLN | SciClone Pharmaceuticals Inc | 2017-10-13 | director |
 | | 2008-04-09 | director |
| | 2007-12-10 | director |
| | 2004-03-30 | director |
Jon S Saxe Latest Holdings Summary
Jon S Saxe currently owns a total of 3 stocks. Among these stocks, Jon S Saxe owns 17,781 shares of Durect Corp (DRRX) as of June 10, 2019, with a value of $23,649 and a weighting of 70.86%. Jon S Saxe owns 1,775 shares of Vistagen Therapeutics Inc (VTGN) as of August 21, 2020, with a value of $5,574 and a weighting of 16.7%. Jon S Saxe also owns 1,680 shares of PDL BioPharma Inc (PDLI) as of April 18, 2006, with a value of $4,150 and a weighting of 12.43%.
Latest Holdings of Jon S Saxe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRRX | Durect Corp | 2019-06-10 | 17,781 | 1.33 | 23,649 |
| VTGN | Vistagen Therapeutics Inc | 2020-08-21 | 1,775 | 3.14 | 5,574 |
| PDLI | PDL BioPharma Inc | 2006-04-18 | 1,680 | 2.47 | 4,150 |
Holding Weightings of Jon S Saxe
Jon S Saxe Form 4 Trading Tracker
According to the SEC Form 4 filings, Jon S Saxe has made a total of 0 transactions in Durect Corp (DRRX) over the past 5 years. The most-recent trade in Durect Corp is the acquisition of 2,500 shares on June 10, 2019, which cost Jon S Saxe around $13,750.
According to the SEC Form 4 filings, Jon S Saxe has made a total of 1 transactions in Vistagen Therapeutics Inc (VTGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vistagen Therapeutics Inc is the acquisition of 1,000 shares on August 21, 2020, which cost Jon S Saxe around $20,700.
According to the SEC Form 4 filings, Jon S Saxe has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the sale of 5,000 shares on April 18, 2006, which brought Jon S Saxe around $150,050.
Insider Trading History of Jon S Saxe
- 1
Jon S Saxe Trading Performance
GuruFocus tracks the stock performance after each of Jon S Saxe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jon S Saxe is 47.24%. GuruFocus also compares Jon S Saxe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jon S Saxe within 3 months outperforms 6 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jon S Saxe's insider trading performs compared to the benchmark.
Performance of Jon S Saxe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.16 | | | | | |
| Relative Return to S&P 500(%) | -1.56 | | | | | |
Jon S Saxe Ownership Network
Ownership Network List of Jon S Saxe
Ownership Network Relation of Jon S Saxe
Jon S Saxe Owned Company Details
What does Vistagen Therapeutics Inc do?
Who are the key executives at Vistagen Therapeutics Inc?
Jon S Saxe is the director of Vistagen Therapeutics Inc. Other key executives at Vistagen Therapeutics Inc include Chief Operating Officer Joshua S. Prince , CHIEF FINANCIAL OFFICER Cynthia Lynn Anderson , and 10 percent owner Commodore Capital Lp .
Vistagen Therapeutics Inc (VTGN) Insider Trades Summary
Over the past 18 months, Jon S Saxe made no insider transaction in Vistagen Therapeutics Inc (VTGN). Other recent insider transactions involving Vistagen Therapeutics Inc (VTGN) include a net purchase of 775,756 shares made by Commodore Capital Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Vistagen Therapeutics Inc (VTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vistagen Therapeutics Inc (VTGN) were sold and 775,756 shares were bought by its insiders, resulting in a net purchase of 775,756 shares.
Vistagen Therapeutics Inc (VTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vistagen Therapeutics Inc Insider Transactions
Jon S Saxe Mailing Address
Above is the net worth, insider trading, and ownership report for Jon S Saxe. You might contact Jon S Saxe via mailing address: First Horizon Pharmaceutical Corp, 660 Hembree Pkwy Ste 106, Roswell Ga 30076.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
